about
Anti-EGFR antibody efficiently and specifically inhibits human TSC2-/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM.Glycosaminoglycans co-administration enhance insulin-like growth factor-I neuroprotective and neuroregenerative activity in traumatic and genetic models of motor neuron disease: a review.TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis.The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cellsThe Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer.Chromatin remodeling by rosuvastatin normalizes TSC2-/meth cell phenotype through the expression of tuberin.Neural stem cell transplantation in experimental contusive model of spinal cord injury.Viability-dependent promoting action of adult neural precursors in spinal cord injury.Grafted Neural Precursors Integrate Into Mouse Striatum, Differentiate and Promote Recovery of Function Through Release of Erythropoietin in MPTP-Treated Mice.Muscle reinnervation following neonatal nerve crush. Interactive effects of glycosaminoglycans and insulin-like growth factor-I.Erythropoietin: recent developments in the treatment of spinal cord injuryDenervation and hyperinnervation in the nervous system of diabetic animals. II. Monoaminergic and peptidergic alterations in the diabetic encephalopathy.Neuroendocrinological study of opioid and serotoninergic systems in migraine patients.Acute spinal cord injury reduces brain derived neurotrohic factor expression in rat hippocampus.Acrylate end-capped poly(ester-carbonate) and poly(ether-ester)s for polymer-on-multielectrode array devices: synthesis, photocuring, and biocompatibility.Recovery from experimental parkinsonism by intrastriatal application of erythropoietin or EPO-releasing neural precursors.Functional interaction between rat substantia nigra and striatum: GABA and dopamine interrelation.Changes in specific activity of dopamine metabolites as evidence of a multiple compartmentation of dopamine in striatal neurons.Diabetes-induced alterations of central nervous system G proteins. ADP-ribosylation, immunoreactivity, and gene-expression studies in rat striatum.Perinatal morphine exposure alters peptidergic development in the striatum.Neurochemical changes of long-term adrenalectomy in rat brain: effects on neurotransmitter amino acids.Peripheral nerve lesions cause simultaneous alterations of substance P and enkephalin levels in the spinal cord.Hormonal imputs and brain tryptophan metabolism: the effect of growth hormone.Brain beta-endorphin concentrations in experimental chronic liver disease.Met-enkephalin immunoreactivity in blood platelets.Development of a lymphangioleiomyomatosis model by endonasal administration of human TSC2-/- smooth muscle cells in mice.Third trimester NG2-positive amniotic fluid cells are effective in improving repair in spinal cord injury.Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations.G protein-mediated signal transduction is affected in primary biliary cirrhosis.Enhanced brain release of erythropoietin, cytokines and NO during carotid clamping.The developmental pattern of met-enkephalin innervation is altered in animals perinatally exposed to morphine.Embryonic stem cells promote motor recovery and affect inflammatory cell infiltration in spinal cord injured mice.Perinatal morphine treatment inhibits pruning effect and regeneration of serotoninergic pathways following neonatal 5,7-HT lesionsCo-administration of IGF-I and glycosaminoglycans greatly delays motor neurone disease and affects IGF-I expression in the wobbler mouse: a long-term studyGlycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection: blockade of motor neuron death in the wobbler mouseLong-term neuroprotective effects of glycosaminoglycans-IGF-I cotreatment in the motor neuron degeneration (mnd ) mutant mouseGlycosaminoglycan Supplementation Promotes Nerve Regeneration and Muscle ReinnervationPerinatal exposure to morphine: reactive changes in the brain after 6-hydroxydopamine
P50
Q33380187-AB7EF204-78BC-4365-9ED0-0420ED572160Q33922338-428D0382-6B85-4DCB-982B-C043E2641CA7Q33991599-C93F7C7E-B97E-4C28-80EC-9C0DCCAC80D5Q34132516-12135B68-E483-4059-9B02-3E7987E67582Q35074335-E2CBA06E-77C1-4A6E-93EA-6D88D8991D6AQ37197352-3E7BE34F-3589-4DB8-8E1D-33EF21966F9DQ38769820-96493CD5-8272-4D08-8158-CBFA8BBB20F9Q39191279-252EA8EB-0CAD-4978-9209-2F90552059B3Q39633938-4E155C62-58A9-4755-8987-6EC82380B4C0Q40797863-559C3647-83E8-4C99-8F39-8F47076DAB84Q42371418-DA33DFCC-D97D-45B8-AF59-E968082D3824Q42450805-62093EE6-B7B6-41E0-A08D-E26585ACE799Q42797884-30DC4516-7AE7-41F6-9A20-42D56EC954D5Q44138057-FF79EEB9-3A29-4B45-B97E-41C7500C64EFQ44351856-8B140436-F9F4-4349-B53B-D6A00F462505Q44410453-7A699819-6EC6-426F-B2EB-F5CFE0E01510Q46766677-219D3C74-BD5D-4B47-9241-FC789AFA95D4Q48232355-EAC5E25E-E00F-440F-8C9F-C7156481FD5BQ48258138-6C3E2947-77F4-48C8-A223-310D724B9AB4Q48328002-0E31EC4E-8641-4BAB-8DF0-97FBA11E2C1DQ48396882-93A0BBE4-E289-425A-93E0-C80E7E58F320Q48404708-33B46CFB-EEB1-49DC-965E-068A3F558E42Q48427206-D8BCB894-A466-4C5C-B552-CC86545E30E9Q48453656-66E39906-69EC-4946-9200-19FFCB5178FFQ48470140-343A0945-7DC2-41C9-BC0C-27CBE0D38B75Q48898346-2B429DA6-B260-475B-9B59-CC3F453BC440Q48944577-C8C1F30B-8C2C-4DE2-AC10-8DE2E143685EQ51327159-5F955B87-58FC-4467-A72E-C0D98605A730Q51755583-3A1AB83E-E8A9-4EDD-A0C1-41704CA75FDBQ51809389-20600298-73A5-4CDA-ABD2-51ECD8DA107BQ51813330-E507D552-9F70-4D10-A2BB-22D0D51B1AEBQ52147638-8D936756-A0E5-49A2-A797-76CAB39DDEE2Q52244546-EA22FDCD-E2DD-47EB-841D-FD6DA2555481Q54444922-93C1ABA1-DBA4-4A07-85B9-6B4B6633615BQ60618632-107780BB-F9EC-471D-96ED-595CE4B5A09EQ60649901-8D3C5B9A-4310-4903-94D8-11775C4DCC97Q60649902-AF2BD622-246F-48A4-AEEE-07C3C6758175Q60649903-9E994AA2-667D-45CE-96D9-9A38BED538E7Q60649904-B4A8DFD9-067D-4327-989C-F728C81FB53DQ60649906-DEEF9271-DA40-4B71-B367-C587B885F4DA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Maria Di Giulio
@ast
Anna Maria Di Giulio
@en
Anna Maria Di Giulio
@es
Anna Maria Di Giulio
@nl
Anna Maria Di Giulio
@sl
type
label
Anna Maria Di Giulio
@ast
Anna Maria Di Giulio
@en
Anna Maria Di Giulio
@es
Anna Maria Di Giulio
@nl
Anna Maria Di Giulio
@sl
prefLabel
Anna Maria Di Giulio
@ast
Anna Maria Di Giulio
@en
Anna Maria Di Giulio
@es
Anna Maria Di Giulio
@nl
Anna Maria Di Giulio
@sl
P106
P1153
7006329575
P21
P31
P496
0000-0002-5702-4623